NaviGate Cardiac Structures Inc. (“NCSI”) Reports World’s First Transcatheter Tricuspid Valved Stent is Successfully Implanted

PRESS RELEASE: LAKE FOREST, Calif.–(BUSINESS WIRE)–December 30, 2016– NaviGate Cardiac Structures Inc. (“NCSI”) announced today that a novel valved stent that can capture the enlarged annulus in patients suffering from functional tricuspid regurgitation (FTR) was implanted in a patient presenting with massive incompetence of the tricuspid valve. The patient, a 64-year-old female with an extensive history of severe tricuspid regurgitation (TR 4+) that invariably resu